StockData

GPGI vs HeartSciences

GPGI and HSCS side by side, both in finance services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How GPGI and HSCS compare

GPGI is the larger company, worth 396 times as much as HeartSciences ($3.9B against $9.9M).

GPGI pays a dividend yielding 0.07%; HeartSciences does not pay one.

GPGI scores higher on the StockData Score (8 against 3 for HeartSciences), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricGPGIHSCS
Size and price
Market cap$3.9B$9.9M
Share price$13.51$2.06
Change, 1 year−32.0%−32.9%
Change, 5 years32.7%–
Beta (5Y)0.64−1.54
Employees971–
StockData Score
Total score8 (better)3
Valuation score00
Growth score00
Performance score1 (better)0
Health score6 (better)3
Dividend score1 (better)0
Valuation
P/S–2188×
P/B1.2×–
Fair value$5.15–
Margin of safety−162%–
Growth
Revenue growth (TTM)−100%–
Revenue growth, 5Y average−25.5%–
Profitability
Gross margin–60.9%
Operating margin–−209733%
Net margin–−227024%
Return on equity−20.6% (better)−1852%
Return on invested capital−4.2%–
Financial health
Debt / equity0.00–
Interest coverage–−11.8×
Current ratio1.14 (better)0.14
Altman Z-score7.77 (better)−42.02
Piotroski F-score34 (better)
Dividends and buybacks
Dividend yield0.07% (better)0.00%
Years of dividend growth–0
Shareholder yield0.07% (better)0.00%
Ownership
Held by institutions94.4%12.8%
Held by insiders56.8%19.2%
Insider net buying, 12 months$1.7M–
Superinvestors holding2–
Short interest, % of float20.1%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.